An update on oculocerebrocutaneous (Delleman-Oorthuys) syndrome.
Ute MoogWilliam B DobynsPublished in: American journal of medical genetics. Part C, Seminars in medical genetics (2019)
Oculocerebrocutaneous syndrome (OCCS) is a rare disorder characterized primarily by congenital skin, eye, and brain anomalies. The most distinctive findings are hypoplastic or aplastic skin defects; pedunculated, typically hamartomatous, or nodular skin appendages; cystic microphthalmia; and a combination of forebrain anomalies and a specific mid-hindbrain malformation. Based on a review of 40 patients with OCCS, existing clinical criteria have been revised. Because of the asymmetric and patchy distribution of features, lack of recurrence in families, male preponderance and completely skewed X-inactivation in one female, OCCS is hypothesized to result from postzygotic mosaic variants in an X-linked gene. Whole exome and genome sequencing on blood DNA in two patients failed to identify pathogenic variants so far. In view of the overlapping features, in particular of the brain, of OCCS and Aicardi syndrome, both may be pathogenetically related or even result from different variants in the same gene. For the elucidation of the cause of OCCS, exome or genome sequencing on multiple lesional tissues is the primary goal.
Keyphrases
- copy number
- genome wide
- soft tissue
- end stage renal disease
- dna methylation
- case report
- ejection fraction
- single cell
- wound healing
- resting state
- newly diagnosed
- gene expression
- white matter
- prognostic factors
- chronic kidney disease
- multiple sclerosis
- peritoneal dialysis
- circulating tumor
- functional connectivity
- allogeneic hematopoietic stem cell transplantation
- acute myeloid leukemia
- single molecule
- acute lymphoblastic leukemia
- brain injury
- transcription factor
- circulating tumor cells
- high throughput sequencing